Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 250 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Jayendrakumar P.

India

USD 250 /hr

M.Pharma, Ph.D.(Pr.), MBA, FSFRC, FIPES, IAOTP Honoured Member

Profile Summary

Professional Summary: A. Formulation Development: Vast expertise and experience (10+ Years) in development of Generic (ANDA) and 505(b)(2) products, including complex and conventional products. Successfully developed products range from complex oral dosage forms such as Multi-layers Osmotic, Powder for Suspension, Pellets, reservoir and matrix-controlled release dosage forms, ODTs, to conventional IR tablets, Hard/Soft gelatine capsules for USA, Europe and India Market. This is supported by 15+ dossier filling with various regulatory agencies with a number of these products being commercialized in various markets. Proven ability to develop and manage multiple research programmes with strong technical background and project management skill in formulation development, process development and overseas technology transfer to filling with regulatory for US, Europe and India. Lead Global Technology Transfer of New Pharmaceutical Dosage Form. Extensive experience in Product Development, Process Development, Process Optimization, Process Scale-up and Technology Transfer to commercial operation site. Execution of documents for licensing activity for new pharmaceutical product, Scale-UP and Regulatory submission documents. B. Specialties Strong Pharmaceutical formulation and analytical, problem solving and decision-making skills with ability to Identify complex problems and offer effective solutions through development or modification of test methodology as well as making non-infringing strategy for generic pharmaceutical product. Extensive knowledge about Patent Application Drafting, Filling and Prosecution of Patent Application with different Patent Offices: India Patent Office, United State-USPTO, Canada Patent Office and WIPO-PCT. More than 12 approved and pending patent application. C. Technical R&D Consultation: Lead and Developed Natoli Scientific Business with Leading Pharma R&D facilities in India by bridging the engineering knowledge with formulation scientist knowledge to developed innovative sustainable high quality pharmaceutical product D. Editor and Reviewer for Leading Scientific Journals Reviewer for more than 16 International well reputed pharmaceutical journals include European Heart Journal (IF 22), Journal of Controlled Release (IF 8), AAPS PharmSciTech Journal, Advanced Healthcare Materials, European Journal of Pharmaceutical Science, Critical Reviews in Oncology/Hematology, International Journal of Pharma and Bio Sciences(IF 8), Drug & Alcohol Dependence, Respiratory Medicine, etc, wherein more than 150 review to my credit. I am editorial board member, including Editor-In-Chief (in more than 10 journals) and serving as role of Reviewer (more than 150 review to my credit) in many well reputed International Pharmaceutical Journals as well as invited as judge/poster screener and keynote speaker in many national and international pharmaceutical conferences.

Subject Matter Expertise

• ★ Pharmacovigilance/Drug Safety Monitoring
• ★ Pharmaceutical Technology
• ☆ Clinical Trials
• ☆ Pharmaceutical Management

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Clinical Trial Documentation, Technical Writing, Copywriting, Newswriting

Research User Research, Meta-Research, Feasibility Study, Fact Checking, Gap Analysis, Systematic Literature Review

Consulting Regulatory Consulting

Data & AI Statistical Analysis, Data Processing, Data Insights

Product Development Formulation, Stability/Shelf Life Testing, Material Sourcing, Product Validation, Manufacturing, Concept Development

Work Experience

Ganpat University

January 2020 - Present

Technical Lead

Natoli Engineering Company, USA

October 2019 - Present

Director & Chief Executive Officer

Pyrrhic Pharma Private Limited

October 2019 - Present

Research Scientist

Xylopia Lab Private Limited

July 2019 - September 2019

Deputy Manager

Zydus Cadila

August 2014 - June 2019

Research Scientist

Alkem Laboratories Ltd

March 2014 - August 2014

Research Assistant

Sun Pharma Advanced Research (India)

July 2011 - March 2014

Education

Ph.D. (Pharmaceutical Science)

Ganpat University

- Present

Master in Industrial Pharmacy (M. Pharma)

Ganpat University

2009 - 2011

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel (2021). COVID-19 Potential To Infect 4.44% Indian Population . The Journal of Pharmaceutical Sciences and Medicinal Research.

Jayendrakumar Patel, Shalin Parikh, Shwetaben Patel, Ronak Patel, Payalben Patel (2021). Carbon Nanotube (CNTs): Structure, Synthesis, Purification, Functionalisation, Pharmacology, Toxicology, Biodegradation and Application as Nanomedicine and Biosensor . The Journal of Pharmaceutical Sciences and Medicinal Research.

Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel (2021). Role of Secondary Attack Rate in The Surge of COVID 19 Cases: A Comparative Retrospective Cohort Study between First Wave and Second Wave of COVID 19 . The Journal of Pharmaceutical Sciences and Medicinal Research.

Jayendrakumar Patel, Shalin Parikh, Shwetaben Patel(2021). A Comprehensive Overview On The Most Recent Trends In Covid-19 Diagnosis, Treatment Options And Vaccine Development Status . The Journal of Pharmaceutical Sciences and Medicinal Research. 001. (01). The Journal of Pharmaceutical Sciences and Medicinal Research

Jayendrakumar Patel, Shalin Parikh, Ronak Patel, Shwetaben Patel(2021). Art Of Designing A Novel Drug Formulation With Patient In Mind . The Journal of Pharmaceutical Sciences and Medicinal Research. 001. (01). The Journal of Pharmaceutical Sciences and Medicinal Research

Jayendrakumar Patel, Shalin Parikh, Shwetaben Patel(2021). Fabrication And In-Vitro Analysis Of Mouth Dissolving Tablets Of Ondansetron Using Water Insoluble Super Disintegrant . The Journal of Pharmaceutical Sciences and Medicinal Research. 001. (01). The Journal of Pharmaceutical Sciences and Medicinal Research

Jayendrakumar Patel, Mamta Nasit, Meshva Patel, Ajay Solanki(2021). Solid-State Lipid - Based Lipid Drug Delivery System . The Journal of Pharmaceutical Sciences and Medicinal Research. 001. (01). The Journal of Pharmaceutical Sciences and Medicinal Research

(2012). Single Core Osmotic Pump (SCOP): Development of Single Layer Osmotic controlled release tablet for poorly soluble drug . Journal of Pharmaceutical Technology and Drug Research.

OTHER

Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel(2021). Unrestricted Social Interaction: Underappreciated Cause of COVID 19 Surge . Research Square Platform {LLC}

Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel (2021). COVID-19 Potential To Infect 4.44% Indian Population .

Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel (2021). COVID-19 Potential To Infect 4.44% Indian Population .

CONFERENCE POSTER

(2011). Formulation and Development of Single layer osmotic controlled release tablet of Sertraline Hydrochloride.

PATENT

A Novel Oral Gastroretentive Pharmaceutical Dosage Form.

A Novel Pulsatile Drug Delivery System.

Abuse Deterrent Pharmaceutical Composition: Therapeutically Effective For A Patient And Deterrent To An Abuser.

Extended Release Osmotic Dosage Forms Comprising High Methylphenidate Hydrochloride Load.

Pharmaceutical Abuse Deterrent Composition Constructed in More Than One Strength.

Pharmaceutical Abuse Deterrent Dosage Form.

Tamper Resistant Pharmaceutical Composition.